Weng CF

ORCID: 0000-0002-9747-8697 · 2 papers in corpus
2020
Medicine ·doi:10.1097/md.0000000000020808

RationalePalbociclib (PAL) is a first-in-class selective inhibitor of the cyclin-dependent kinases 4 (CDK4) and CDK6 and is indicated for the treatment of hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-negati…

2019
Therapeutic advances in chronic disease ·doi:10.1177/2040622319875305

Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1. In diabe…